We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+4.24%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.31B
AUM Growth
+$60.9M
Cap. Flow
-$73.3M
Cap. Flow %
-1.7%
Top 10 Hldgs %
16.36%
Holding
590
New
34
Increased
175
Reduced
265
Closed
22

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$26.3M
2
OKE icon
Oneok
OKE
+$18.5M
3
BAX icon
Baxter International
BAX
+$17.2M
4
AVY icon
Avery Dennison
AVY
+$12.8M
5
ICUI icon
ICU Medical
ICUI
+$11.8M

Top Sells

Rank Stock Value
1
AYI icon
Acuity Brands
AYI
+$23.3M
2
PPG icon
PPG Industries
PPG
+$22.4M
3
EFX icon
Equifax
EFX
+$19M
4
OKS
Oneok Partners LP
OKS
+$17.7M
5
MDT icon
Medtronic
MDT
+$17.5M

Sector Composition

Rank Sector Weight
1 Healthcare 17.99%
2 Industrials 16.07%
3 Financials 14.59%
4 Technology 13.97%
5 Consumer Discretionary 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
126
Oracle
ORCL
$331B
$8.4M 0.2%
173,749
+20,710
+14% +$1.03M
PRGS icon
127
Progress Software
PRGS
$1.55B
$8.37M 0.19%
219,290
-42,668
-16% -$1.43M
UPS icon
128
United Parcel Service
UPS
$97.6B
$8.31M 0.19%
69,165
+830
+1% +$94.4K
HZNP
129
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$8.16M 0.19%
643,928
+52,454
+9% +$667K
MRK icon
130
Merck
MRK
$324B
$8.07M 0.19%
132,013
-388
-0.3% -$23.5K
PMC
131
DELISTED
PharMerica Corporation
PMC
$7.85M 0.18%
268,060
-11,549
-4% -$324K
BIO icon
132
Bio-Rad Laboratories Class A
BIO
$8.42B
$7.81M 0.18%
35,153
+3,790
+12% +$853K
NBHC icon
133
National Bank Holdings
NBHC
$1.93B
$7.78M 0.18%
217,961
-53,779
-20% -$1.78M
CVX icon
134
Chevron
CVX
$388B
$7.72M 0.18%
65,744
+1,845
+3% +$201K
MZTI
135
The Marzetti Company
MZTI
$2.94B
$7.7M 0.18%
64,126
+16,686
+35% +$2.01M
RNST icon
136
Renasant Corp
RNST
$4.01B
$7.62M 0.18%
177,560
-3,680
-2% -$152K
LYB icon
137
LyondellBasell Industries
LYB
$19.5B
$7.53M 0.17%
75,983
+1,202
+2% +$108K
GGG icon
138
Graco
GGG
$12.9B
$7.45M 0.17%
180,768
-25,251
-12% -$962K
META icon
139
Meta Platforms (Facebook)
META
$1.51T
$7.39M 0.17%
43,232
-90
-0.2% -$15K
GWW icon
140
W.W. Grainger
GWW
$65.3B
$7.32M 0.17%
40,704
-3,863
-9% -$652K
EFA icon
141
iShares MSCI EAFE ETF
EFA
$76.4B
$7.31M 0.17%
106,740
+2,802
+3% +$187K
DBI icon
142
Designer Brands
DBI
$277M
$7.29M 0.17%
339,498
-7,745
-2% -$142K
NFX
143
DELISTED
Newfield Exploration
NFX
$7.13M 0.17%
240,193
+207,339
+631% +$5.57M
WAL icon
144
Western Alliance Bancorporation
WAL
$9.07B
$7.11M 0.17%
+134,005
New +$6.57M
EPC icon
145
Edgewell Personal Care
EPC
$1.27B
$6.95M 0.16%
95,568
-2,739
-3% -$202K
WWD icon
146
Woodward
WWD
$25B
$6.9M 0.16%
88,926
-24,400
-22% -$1.72M
PCH
147
DELISTED
PotlatchDeltic
PCH
$6.81M 0.16%
133,584
+282
+0.2% +$13.4K
BUSE icon
148
First Busey Corp
BUSE
$2.52B
$6.78M 0.16%
216,233
-4,895
-2% -$143K
PGR icon
149
Progressive
PGR
$124B
$6.68M 0.16%
138,057
– –
BNY
150
Bank of New York Mellon
BNY
$108B
$6.68M 0.16%
125,950
+2,721
+2% +$143K
4 5
6
7 8

Similar funds

DE
Defiance ETFs New York $6.98B AUM
STA
Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $6.98B AUM
RBI
Raiffeisen Bank International Vienna, Austria $6.97B AUM 29.39% 1-Year Est. Return
PFA
Pure Financial Advisors San Diego, California $6.97B AUM 16.14% 1-Year Est. Return
CWM
Circle Wealth Management Summit, New Jersey $7.02B AUM 19.32% 1-Year Est. Return
RPI
Railway Pension Investments London, United Kingdom $7.03B AUM 18.92% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Segall Bryant & Hamill's Q3 2017 Portfolio in Review

As of Q3 2017, Segall Bryant & Hamill held 590 positions worth $4.31B, up 1.4% from $4.24B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Segall Bryant & Hamill's Q3 2017 filing shows 34 new, 175 increased, 265 reduced and 22 closed positions. Its largest new stake was ICU Medical: 67,735 shares worth $12.6M. The largest sale was Acuity Brands, an estimated $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q3 2017 buy was ICU Medical: 67,735 shares worth $12.6M.
  • Segall Bryant & Hamill added most to Thermo Fisher Scientific in Q3 2017, an estimated $26.3M increase.
  • Segall Bryant & Hamill's biggest Q3 2017 reduction was Acuity Brands, cutting an estimated $23.3M.
  • Segall Bryant & Hamill fully exited Oneok Partners LP in Q3 2017, selling an estimated $17.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 16% of its $4.31B portfolio in Q3 2017.
  • Segall Bryant & Hamill opened 34 new positions and closed 22 in Q3 2017.
  • Segall Bryant & Hamill's portfolio value rose 1.4% quarter-over-quarter to $4.31B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2017, filed 14 Nov 2017.